Issued Patents All Time
Showing 1–25 of 34 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12059474 | Methods for selecting antibodies that specifically bind glycosylated immune checkpoint proteins | Stephen Sunghan Yoo | 2024-08-13 |
| 11981736 | Antibodies specific to glycosylated PD-1 and methods of use thereof | Stephen Sunghan Yoo, Ezra Myung Chul Chung, Yong-Soo Kim, Seung-Oe LIM, Chia-Wei Li | 2024-05-14 |
| 11933786 | Antibodies specific to glycosylated PD-L1 and methods of use thereof | Stephen Sunghan Yoo, Ezra Myung Chul Chung, Yong-Soo Kim, Chia-Wei Li, Seung-Oe LIM | 2024-03-19 |
| 11746152 | Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1 | Stephen Sunghan Yoo, Chia-Wei Li, Seung-Oe LIM | 2023-09-05 |
| 11660352 | Dual function antibodies specific to glycosylated PD-L1 and methods of use thereof | Stephen Sunghan Yoo, Ezra Myung Chul Chung, Yong-Soo Kim, Kyu-Lee Han, Andrew H. Park +2 more | 2023-05-30 |
| 11452775 | Detection of arginine methylation of EGFR for prediction of resistance to therapy | Hsin-Wei Liao, Jung-Mao Hsu | 2022-09-27 |
| 10858432 | Antibodies specific to glycosylated PD-1 and methods of use thereof | Stephen Sunghan Yoo, Ezra Myung Chul Chung, Yong-Soo Kim, Seung-Oe LIM, Chia-Wei Li | 2020-12-08 |
| 10836827 | Antibodies specific to glycosylated PD-L1 and methods of use thereof | Stephen Sunghan Yoo, Ezra Myung Chul Chung, Yong-Soo Kim, Chia-Wei Li, Seung-Oe LIM | 2020-11-17 |
| 10537635 | Detection of arginine methylation of EGFR for prediction of resistance to therapy | Hsin-Wei Liao, Jung-Mao Hsu | 2020-01-21 |
| 10451610 | Prediction of response to PARP inhibitors and combinational therapy targeting C-MET and PARP1 | Yi Du | 2019-10-22 |
| 9655909 | Personalized medicine for the prediction of therapy targeting the hedgehog pathway | Yan Wang, Jaffer Ajani | 2017-05-23 |
| 8586316 | Methods for detecting molecule-molecule interactions with a single detection channel | Jun Kameoka, Nan Jing, Chao-Kai Chou | 2013-11-19 |
| 8304526 | Antitumor effect of mutant Bik | Yan Li, Yong Wen | 2012-11-06 |
| 7906628 | Targeting proteins to deliver therapeutic or diagnostic reagents | Keng-Li Lan, Keng-Hsin Lan, Jaw-Ching Liu, Fu Ou Yang | 2011-03-15 |
| 7893033 | Targeting proteins to deliver therapeutic or diagnostic reagents | Keng-Li Lan, Keng-Hsin Lan, Jaw-Ching Liu, Fu Ou-Yang | 2011-02-22 |
| 7816131 | Cancer specific promoters | Chi-Ping Day, Kun-Ming Rau, Xiaoming Xie, Zheng Li | 2010-10-19 |
| 7723104 | Cancer specific promoters | Chi-Ping Day, Kun-Ming Rau, Xiaoming Xie, Zheng Li | 2010-05-25 |
| 7709205 | 14-3-3 Zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer type | Dihua Yu, Jun Yao, Christopher L. Neal, Wentao Yang, Xiaoyan Zhou +4 more | 2010-05-04 |
| 7316907 | 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types | Dihua Yu, Jun Yao, Christopher L. Neal, Wentao Yang, Xiaoyan Zhou +4 more | 2008-01-08 |
| 7005424 | Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells to chemotherapy | Naoto Ueno | 2006-02-28 |
| 6852483 | Predicting survival of patients with squamous cell carcinoma | Weiya Xia, Yiu-Keung Lau | 2005-02-08 |
| 6683059 | Mini-E1A gene and gene products | Hua Chen, Dihua Yu, Ralph Paul, Aaron Loomis, Daniel Nathan Andrew LaFoc | 2004-01-27 |
| 6582725 | Human PEA3 is a tumor suppressor for cancer cells | Xiangming Xing | 2003-06-24 |
| 6395712 | Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy | Naoto Ueno | 2002-05-28 |
| 6331284 | P202 is a tumor suppressor | Duen-Hwa Yan, Yong Wen, Bill Spohn | 2001-12-18 |